Muñoz Laguna Javier, Kurmann Astrid, Hofstetter Léonie, Nyantakyi Emanuela, Clack Lauren, Bang Heejung, Foster Nadine E, Braun Julia, Puhan Milo A, Farshad Mazda, Hincapié Cesar A
EBPI-UWZH Musculoskeletal Epidemiology Research Group, University of Zurich and Balgrist University Hospital, Zurich, Switzerland.
Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.
Pilot Feasibility Stud. 2024 May 2;10(1):70. doi: 10.1186/s40814-024-01492-6.
Blinding is a methodologically important aspect in randomised controlled trials yet frequently overlooked in trials of spinal manual therapy interventions for back pain. To help inform the blinding methods of a future, double-placebo-controlled trial comparing spinal manual therapy and nerve root injection for lumbosacral radicular pain, we set four objectives: (1) to assess the feasibility of blinding participants, randomly allocated to an active or placebo-control spinal manual therapy intervention protocol, (2) to assess the feasibility of blinding outcome assessors within the trial, (3) to explore the influence of spinal manual therapy experience and low back pain on blinding, and (4) to explore factors contributing to perceptions about intervention assignment among participants and outcome assessors.
Two-parallel-group, single-centre, placebo-controlled, methodological blinding feasibility randomised trial. We will recruit between 60 and 100 adults with or without back pain and with or without experience of spinal manual therapy from Zurich, Switzerland. Participants will be randomised to either an active spinal manual therapy or a placebo-control spinal manual therapy protocol-both interventions delivered over two study visits, up to two weeks apart. The primary outcome is participant blinding using the Bang blinding index within each intervention arm immediately after each of the two study visits. Secondary outcomes are participant blinding using the James blinding index, outcome assessor blinding (Bang and James blinding indices), self-reported factors influencing perceived intervention assignment among participants and outcome assessors, and participant-reported credibility and expectancy of study interventions. Other outcomes-included to blind the study objective from participants-are lumbar spine range of motion, self-rated general health, satisfaction with care, pain intensity, and function. Intervention provider outcomes include intervention component fidelity and quality of intervention delivery.
The independent ethics commission of Canton Zurich granted ethical approval for this study (KEK 2023-00381). Written informed consent will be obtained from all participants. Findings will be disseminated in scientific conferences and a peer-reviewed publication and inform the blinding methods of a future double-placebo controlled trial comparing spinal manual therapy and nerve root injection for lumbosacral radicular pain-the SALuBRITY trial.
NCT05778396.
设盲是随机对照试验中一个重要的方法学方面,但在腰痛的脊柱手法治疗干预试验中经常被忽视。为了为未来一项比较脊柱手法治疗和神经根注射治疗腰骶部神经根性疼痛的双安慰剂对照试验的设盲方法提供参考,我们设定了四个目标:(1)评估将参与者随机分配到积极或安慰剂对照脊柱手法治疗干预方案后使其设盲的可行性,(2)评估试验中结果评估者设盲的可行性,(3)探讨脊柱手法治疗经验和腰痛对设盲的影响,(4)探讨导致参与者和结果评估者对干预分配认知的因素。
两平行组、单中心、安慰剂对照、方法学设盲可行性随机试验。我们将从瑞士苏黎世招募60至100名有或无背痛、有或无脊柱手法治疗经验的成年人。参与者将被随机分配到积极脊柱手法治疗或安慰剂对照脊柱手法治疗方案——两种干预均在两次研究访视中进行,访视间隔最长两周。主要结局是在两次研究访视每次结束后,使用邦设盲指数评估各干预组内参与者的设盲情况。次要结局包括使用詹姆斯设盲指数评估参与者的设盲情况、结果评估者的设盲情况(邦和詹姆斯设盲指数)、参与者和结果评估者自我报告的影响其对干预分配认知的因素,以及参与者报告的研究干预的可信度和预期。为使参与者对研究目的不知情而纳入的其他结局包括腰椎活动范围、自我评定的总体健康状况、护理满意度、疼痛强度和功能。干预提供者的结局包括干预组成部分的保真度和干预实施的质量。
苏黎世州独立伦理委员会批准了本研究(KEK 2023 - 00381)。将获得所有参与者的书面知情同意。研究结果将在科学会议和同行评审出版物上发表,并为未来一项比较脊柱手法治疗和神经根注射治疗腰骶部神经根性疼痛的双安慰剂对照试验——SALuBRITY试验的设盲方法提供参考。
NCT05778396。